ARTICLE | Distillery Techniques
Drug platforms
April 3, 2018 6:13 PM UTC
Nuclear-targeted, catalytically inactive Ruminococcus flavefaciens Cas13d could be used for therapeutic targeting of single-stranded RNAs and RNA splicing in cell nuclei. The fusion consists of Cas13d...
BCIQ Company Profiles